Singapore markets closed

Humanigen, Inc. (HGEN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1800-0.2600 (-10.66%)
At close: 04:00PM EDT
2.2200 +0.04 (+1.83%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.4400
Open2.4900
Bid2.2000 x 36200
Ask2.2400 x 2900
Day's range2.0801 - 2.5750
52-week range1.6700 - 18.6800
Volume7,195,801
Avg. volume1,346,180
Market cap153.981M
Beta (5Y monthly)-1.02
PE ratio (TTM)N/A
EPS (TTM)-3.1140
Earnings date10 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.43
  • Business Wire

    Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

    SHORT HILLS, N.J., June 16, 2022--Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ today announced it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (UK) for lenzilumab. Under the agreement,

  • Business Wire

    Humanigen Announces Participation and Presentation at Multiple Conferences in June

    SHORT HILLS, N.J., June 03, 2022--Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ announced today that representatives will present and participate at multiple investors conferences in June 2022. Details of the conferences are as follows:

  • Business Wire

    Humanigen Announces Participation and Presentation at H.C. Wainwright Global Investment Conference

    SHORT HILLS, N.J., May 24, 2022--Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ announced that Cameron Durrant, Chairman & CEO, will give a corporate presentation at 11:00am EDT today at the H.C. Wainwright Global Investment Conference taking place in Miami, FL, May 23-26, 2022. In his presentation Dr. Durrant will provide an update on progress towards release of top